PTSD: from neurobiology to pharmacological treatments

References

• Abdallah C.G., Sanacora G., Duman R.S., Krystal J.H. Ketamine and rapid-acting antidepressants: A window into a new neurobiology for mood disorder therapeutics. Annual Review of Medicine. 2015; 66: 509–523. doi: http://dx.doi.org/10.1146/annurev-med-053013-062946.
   Google Scholar
• Alexander B., Lund B.C., Bernardy N.C., Christopher M.L., Friedman M.J. Early discontinuation and suboptimal dosing of prazosin: A potential missed opportunity for veterans with posttraumatic stress disorder. Journal of Clinical Psychiatry. 2015; 76(5): e639–e644. doi: http://dx.doi.org/10.4088/JCP.14m09057.
   Google Scholar
• Alexander W . Pharmacotherapy for posttraumatic stress disorder in combat veterans: Focus on antidepressants and atypical antipsychotic agents. P T. 2012; 37(1): 32–38.
   Google Scholar
• Atsak P., Roozendaal B., Campolongo P. Role of the endocannabinoid system in regulating glucocorticoid effects on memory for emotional experiences. Neuroscience. 2012; 204: 104–116. doi: http://dx.doi.org/10.1016/j.neuroscience.2011.08.047.
   Google Scholar
• Attari A. , Rajabi F. , Maracy M.R . D-cycloserine for treatment of numbing and avoidance in chronic posttraumatic stress disorder: A randomized, double blind, clinical trial. Journal of Research in Medical Sciences. 2014; 19(7): 592–598.
   Google Scholar
• Bailey C.R., Cordell E., Sobin S.M., Neumeister A. Recent progress in understanding the pathophysiology of posttraumatic stress disorder: Implications for targeted pharmacological treatment. CNS Drugs. 2013; 27(3): 221–232. doi: http://dx.doi.org/10.1007/s40263-013-0051-4.
   Google Scholar
• Benedek D.M. , Friedman M.J. , Zatzick D. , Ursano R.J . Guideline watch (March 2009): Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. Journal of Lifelong Learning. 2009; 7: 204–2013.
   Google Scholar
• Berger W., Mendlowicz M.V., Marques-Portella C., Kinrys G., Fontenelle L.F., Marmar C.R., …, Figueira I. Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review. Progress in Neuro-psychopharmacology. Biological Psychiatry. 2009; 33(2): 169–180. doi: http://dx.doi.org/10.1007/10.1016/j.pnpbp.2008.12.004.
   Google Scholar
• Berman R.M. , Cappiello A. , Anand A. , Oren D.A. , Heninger G.R. , Charney D.S., … , Krystal J.H . Antidepressant effects of ketamine in depressed patients. Biological Psychiatry. 2000; 47(4): 351–354.
   Google Scholar
• Bonn-Miller M.O., Boden M.T., Bucossi M.M., Babson K.A. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. American Journal of Drug and Alcohol Abuse. 2014; 40(1): 23–30. doi: http://dx.doi.org/10.1007/10.3109/00952990.2013.821477.
   Google Scholar
• Bonn-Miller M.O., Vujanovic A.A., Feldner M.T., Bernstein A., Zvolensky M.J. Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users. Journal of Traumatic Stress. 2007; 20(4): 577–586. doi: http://dx.doi.org/10.1007/10.1002/jts.20243.
   Google Scholar
• Brady K. , Pearlstein T. , Asnis G.M. , Baker D. , Rothbaum B. , Sikes C.R., … , Farfel G.M . Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. Journal of the American Medical Association. 2000; 283(14): 1837–1844.
   Google Scholar
• Bremner J.D., Southwick S.M., Darnell A., Charney D.S. Chronic PTSD in Vietnam combat veterans: Course of illness and substance abuse. American Journal of Psychiatry. 1996; 153(3): 369–375. doi: http://dx.doi.org/10.1007/10.1176/ajp.153.3.369.
   Google Scholar
• Bryant R.A., Creamer M., O'Donnell M., Silove D., McFarlane A.C. A study of the protective function of acute morphine administration on subsequent posttraumatic stress disorder. Biological Psychiatry. 2009; 65(5): 438–440. doi: http://dx.doi.org/10.1007/10.1016/j.biopsych.2008.10.032.
   Google Scholar
• Campolongo P., Roozendaal B., Trezza V., Hauer D., Schelling G., McGaugh J.L., …, Cuomo V. Endocannabinoids in the rat basolateral amygdala enhance memory consolidation and enable glucocorticoid modulation of memory. Proceedings of the National Academy Sciences USA. 2009; 106(12): 4888–4893. doi: http://dx.doi.org/10.1007/10.1073/pnas.0900835106.
   Google Scholar
• Chambers R.A., Bremner J.D., Moghaddam B., Southwick S.M., Charney D.S., Krystal J.H. Glutamate and posttraumatic stress disorder: Toward a psychobiology of dissociation. Seminars in Clinical Neuropsychiatry. 1999; 4(4): 274–281. doi: http://dx.doi.org/10.1007/10.153/SCNP00400274.
   Google Scholar
• Charney D.S. Psychobiological mechanisms of resilience and vulnerability: Implications for successful adaptation to extreme stress. American Journal of Psychiatry. 2004; 161(2): 195–216. doi: http://dx.doi.org/10.1007/10.1176/appi.ajp.161.2.195.
   Google Scholar
• Chhatwal J.P., Davis M., Maguschak K.A., Ressler K.J. Enhancing cannabinoid neurotransmission augments the extinction of conditioned fear. Neuropsychopharmacology. 2005; 30(3): 516–524. doi: http://dx.doi.org/10.1007/10.1038/sj.npp.1300655.
   Google Scholar
• Corcoran K.A. , Maren S . Hippocampal inactivation disrupts contextual retrieval of fear memory after extinction. The Journal of Neuroscience. 2001; 21(5): 1720–1726.
   Google Scholar
• D'Andrea D., Andrew Sewell R. Transient resolution of treatment-resistant posttraumatic stress disorder following ketamine infusion. Biological Psychiatry. 2013; 74(9): e13–14. doi: http://dx.doi.org/10.1007/10.1016/j.biopsych.2013.04.019.
   Google Scholar
• D'Souza D.C., Gil R.B., Zuzarte E., MacDougall L.M., Donahue L., Ebersole J.S., …Krystal J H. Gamma-Aminobutyric acid-serotonin interactions in healthy men: Implications for network models of psychosis and dissociation. Biological Psychiatry. 2006; 59(2): 128–137. doi: http://dx.doi.org/10.1007/10.1016/j.biopsych.2005.06.020.
   Google Scholar
• Davidson J., Baldwin D., Stein D.J., Kuper E., Benattia I., Ahmed S., …Musgnung J. Treatment of posttraumatic stress disorder with venlafaxine extended release: A 6-month randomized controlled trial. Archives of General Psychiatry. 2006; 63(10): 1158–1165. doi: http://dx.doi.org/10.1007/10.1001/archpsyc.63.10.1158.
   Google Scholar
• Davidson J.R., Brady K., Mellman T.A., Stein M.B., Pollack M.H. The efficacy and tolerability of tiagabine in adult patients with posttraumatic stress disorder. Journal of Clinical Psychopharmacology. 2007; 27(1): 85–88. doi: http://dx.doi.org/10.1007/10.1097/JCP.0b013e31802e5115.
   Google Scholar
• Davidson J.R. , Rothbaum B.O. , van der Kolk B.A. , Sikes C.R. , Farfel G.M . Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Archives of General Psychiatry. 2001; 58(5): 485–492.
   Google Scholar
• de Kleine R.A., Hendriks G.J., Kusters W.J., Broekman T.G., van Minnen A. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder. Biological Psychiatry. 2012; 71(11): 962–968. doi: http://dx.doi.org/10.1007/10.1016/j.biopsych.2012.02.033.
   Google Scholar
• Del Arco A., Mora F. Neurotransmitters and prefrontal cortex-limbic system interactions: Implications for plasticity and psychiatric disorders. Journal of Neural Transmission (Vienna). 2009; 116(8): 941–952. doi: http://dx.doi.org/10.1007/10.1007/s00702-009-0243-8.
   Google Scholar
• Difede J., Cukor J., Wyka K., Olden M., Hoffman H., Lee F.S., …, Altemus M. D-cycloserine augmentation of exposure therapy for posttraumatic stress disorder: A pilot randomized clinical trial. Neuropsychopharmacology. 2014; 39(5): 1052–1058. doi: http://dx.doi.org/10.1007/10.1038/npp.2013.317.
   Google Scholar
• Feder A., Parides M.K., Murrough J.W., Perez A.M., Morgan J.E., Saxena S., …Charney D.S. Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial. Journal of the American Medical Association Psychiatry. 2014; 71(6): 681–688. doi: http://dx.doi.org/10.1007/10.1001/jamapsychiatry.2014.62.
   Google Scholar
• Feldman R., Vengrober A., Ebstein R.P. Affiliation buffers stress: Cumulative genetic risk in oxytocin-vasopressin genes combines with early caregiving to predict PTSD in war-exposed young children. Translational Psychiatry. 2014; 4: e370. doi: http://dx.doi.org/10.1007/10.1038/tp.2014.6.
   Google Scholar
• Frank J.B., Kosten T.R., Giller E.L.Jr, Dan E. A randomized clinical trial of phenelzine and imipramine for posttraumatic stress disorder. American Journal of Psychiatry. 1988; 145(10): 1289–1291. doi: http://dx.doi.org/10.1007/10.1176/ajp.145.10.1289.
   Google Scholar
• Friedman M.J. , Marmar C.R. , Baker D.G. , Sikes C.R. , Farfel G.M . Randomized, double-blind comparison of sertraline and placebo for posttraumatic stress disorder in a Department of Veterans Affairs setting. Journal of Clinical Psychiatry. 2007; 68(5): 711–720.
   Google Scholar
• Glass M. , Dragunow M. , Faull R.L . Cannabinoid receptors in the human brain: A detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain. Neuroscience. 1997; 77(2): 299–318.
   Google Scholar
• Greer G.R., Grob C.S., Halberstadt A.L. PTSD symptom reports of patients evaluated for the New Mexico Medical Cannabis Program. Journal of Psychoactive Drugs. 2014; 46(1): 73–77. doi: http://dx.doi.org/10.1007/10.1080/02791072.2013.873843.
   Google Scholar
• Gunduz-Cinar O., MacPherson K.P., Cinar R., Gamble-George J., Sugden K., Williams B., …Holmes A. Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity. Molecular Psychiatry. 2013; 18(7): 813–823. doi: http://dx.doi.org/10.1007/10.1038/mp.2012.72.
   Google Scholar
• Haller J. , Bakos N. , Szirmay M. , Ledent C. , Freund T.F . The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety. European Journal of Neuroscience. 2002; 16(7): 1395–1398.
   Google Scholar
• Haller J. , Varga B. , Ledent C. , Freund T.F . CB1 cannabinoid receptors mediate anxiolytic effects: Convergent genetic and pharmacological evidence with CB1-specific agents. Behavioral Pharmacology. 2004; 15(4): 299–304.
   Google Scholar
• Hamner M.B. , Faldowski R.A. , Robert S. , Ulmer H.G. , Horner M.D. , Lorberbaum J.P . A preliminary controlled trial of divalproex in posttraumatic stress disorder. Annual Clinical Psychiatry. 2009; 21(2): 89–94.
   Google Scholar
• Heinrichs M. , Baumgartner T. , Kirschbaum C. , Ehlert U . Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biological Psychiatry. 2003; 54(12): 1389–1398.
   Google Scholar
• Heresco-Levy U., Kremer I., Javitt D.C., Goichman R., Reshef A., Blanaru M., …, Cohen T. Pilot-controlled trial of D-cycloserine for the treatment of posttraumatic stress disorder. International Journal of Neuropsychopharmacology. 2002; 5(4): 301–307. doi: http://dx.doi.org/10.1007/10.1017/S1461145702003061.
   Google Scholar
• Herkenham M. , Lynn A.B. , Little M.D. , Johnson M.R. , Melvin L.S. , de Costa B.R., … , Rice K.C . Cannabinoid receptor localization in brain. Proceedings of National Academy of Sciences USA. 1990; 87(5): 1932–1936.
   Google Scholar
• Hill M.N., McEwen B.S. Endocannabinoids: The silent partner of glucocorticoids in the synapse. Proceedings of National Academy of Sciences USA. 2009; 106(12): 4579–4580. doi: http://dx.doi.org/10.1007/10.1073/pnas.0901519106.
   Google Scholar
• Hysek C.M., Simmler L.D., Ineichen M., Grouzmann E., Hoener M.C., Brenneisen R., Liechti M.E. The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA (“ecstasy”) in humans. Clinical Pharmacology and Therapeutics. 2011; 90(2): 246–255. doi: http://dx.doi.org/10.1007/10.1038/clpt.2011.78.
   Google Scholar
• Koch S.B., van Zuiden M., Nawijn L., Frijling J.L., Veltman D.J., Olff M. Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: Salience processing and fear inhibition processes. Psychoneuroendocrinology. 2014; 40: 242–256. doi: http://dx.doi.org/10.1007/10.1016/j.psyneuen.2013.11.018.
   Google Scholar
• Koch S.B., van Zuiden M., Nawijn L., Frijling J.L., Veltman D.J., Olff M. Intranasal oxytocin normalizes amygdala functional connectivity in posttraumatic stress disorder. Neuropsychopharmacology. 2016; 41(8): 20141–51. doi: http://dx.doi.org/10.1007/10.1038/npp.2016.1.
   Google Scholar
• Krystal J.H., Neumeister A. Noradrenergic and serotonergic mechanisms in the neurobiology of posttraumatic stress disorder and resilience. Brain Research. 2009; 1293: 13–23. doi: http://dx.doi.org/10.1007/10.1016/j.brainres.2009.03.044.
   Google Scholar
• Krystal J.H. , Webb E. , Cooney N.L. , Kranzler H.R. , Southwick S.W. , Heninger G.R., … , Charney D.S . Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects. American Journal of Psychiatry. 1996; 153(1): 83–92.
   Google Scholar
• LeDoux J.E. Emotion circuits in the brain. Annual Review of Neuroscience. 2000; 23: 155–184. doi: http://dx.doi.org/10.1007/10.1146/annurev.neuro.23.1.155.
   Google Scholar
• Leweke F.M., Koethe D. Cannabis and psychiatric disorders: It is not only addiction. Addiction Biology. 2008; 13(2): 264–275. doi: http://dx.doi.org/10.1007/10.1111/j.1369-1600.2008.00106.x.
   Google Scholar
• Liechti M.E., Vollenweider F.X. Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Human Psychopharmacology. 2001; 16(8): 589–598. doi: http://dx.doi.org/10.1007/10.1002/hup.348.
   Google Scholar
• Litz B.T., Salters-Pedneault K., Steenkamp M.M., Hermos J.A., Bryant R.A., Otto M.W., …, Hofmann S.G. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder. Journal of Psychiatric Research. 2012; 46(9): 1184–1190. doi: http://dx.doi.org/10.1007/10.1016/j.jpsychires.2012.05.006.
   Google Scholar
• Lund B.C., Bernardy N.C., Alexander B., Friedman M.J. Declining benzodiazepine use in veterans with posttraumatic stress disorder. Journal of Clinical Psychiatry. 2012; 73(3): 292–296. doi: http://dx.doi.org/10.1007/10.4088/JCP.10m06775.
   Google Scholar
• Lutz B. The endocannabinoid system and extinction learning. Molecular Neurobiology. 2007; 36(1): 92–101. doi: http://dx.doi.org/10.1007/10.1007/s12035-007-8004-x.
   Google Scholar
• Marshall R.D., Beebe K.L., Oldham M., Zaninelli R. Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study. American Journal of Psychiatry. 2001; 158(12): 1982–1988. doi: http://dx.doi.org/10.1007/10.1176/appi.ajp.158.12.1982.
   Google Scholar
• Marsicano G., Wotjak C.T., Azad S.C., Bisogno T., Rammes G., Cascio M.G., …Lutz B. The endogenous cannabinoid system controls extinction of aversive memories. Nature. 2002; 418(6897): 530–534. doi: http://dx.doi.org/10.1007/10.1038/nature00839.
   Google Scholar
• McGhee L.L., Maani C.V., Garza T.H., Gaylord K.M., Black I.H. The correlation between ketamine and posttraumatic stress disorder in burned service members. The Journal of Trauma. 2008; 64(2 Suppl): S195–198; Discussion S197–198. doi: http://dx.doi.org/10.1007/10.1097/TA.0b013e318160ba1d.
   Google Scholar
• Meyerhoff D.J., Mon A., Metzler T., Neylan T.C. Cortical gamma-aminobutyric acid and glutamate in posttraumatic stress disorder and their relationships to self-reported sleep quality. Sleep. 2014; 37(5): 893–900. doi: http://dx.doi.org/10.1007/10.5665/sleep.3654.
   Google Scholar
• Mithoefer M.C., Wagner M.T., Mithoefer A.T., Jerome L., Doblin R. The safety and efficacy of {+/−} 3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: The first randomized controlled pilot study. Journal of Psychopharmacology. 2011; 25(4): 439–452. doi: http://dx.doi.org/10.1007/10.1177/0269881110378371.
   Google Scholar
• Mithoefer M.C., Wagner M.T., Mithoefer A.T., Jerome L., Martin S.F., Yazar-Klosinski B., …Doblin R. Durability of improvement in posttraumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: A prospective long-term follow-up study. Journal of Psychopharmacology. 2013; 27(1): 28–39. doi: http://dx.doi.org/10.1007/10.1177/0269881112456611.
   Google Scholar
• Moghaddam B. , Adams B. , Verma A. , Daly D . Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. Journal of Neuroscience. 1997; 17(8): 2921–2927.
   Google Scholar
• Morgan C.A., 3rd , Rasmusson A.M. , Wang S. , Hoyt G. , Hauger R.L. , Hazlett G . Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: Replication and extension of previous report. Biological Psychiatry. 2002; 52(2): 136–142.
   Google Scholar
• Morgan C.A., 3rd , Wang S. , Southwick S.M. , Rasmusson A. , Hazlett G. , Hauger R.L., … , Charney D.S . Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biological Psychiatry. 2000; 47(10): 902–909.
   Google Scholar
• Murrough J.W., Czermak C., Henry S., Nabulsi N., Gallezot J.D., Gueorguieva R., …Neumeister A. The effect of early trauma exposure on serotonin type 1B receptor expression revealed by reduced selective radioligand binding. Archives of General Psychiatry. 2011; 68(9): 892–900. doi: http://dx.doi.org/10.1007/10.1001/archgenpsychiatry.2011.91.
   Google Scholar
• Neumeister A. The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD. Depression and Anxiety. 2013; 30(2): 93–96. doi: http://dx.doi.org/10.1007/10.1002/da.22031.
   Google Scholar
• Neumeister A., Normandin M.D., Pietrzak R.H., Piomelli D., Zheng M.Q., Gujarro-Anton A., …Huang Y. Elevated brain cannabinoid CB1 receptor availability in posttraumatic stress disorder: A positron emission tomography study. Molecular Psychiatry. 2013; 18(9): 1034–1040. doi: http://dx.doi.org/10.1007/10.1038/mp.2013.61.
   Google Scholar
• Neumeister A., Seidel J., Ragen B.J., Pietrzak R.H. Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder. Psychoneuroendocrinology. 2015; 51: 577–584. doi: http://dx.doi.org/10.1007/10.1016/j.psyneuen.2014.10.012.
   Google Scholar
• Nishi D., Hashimoto K., Noguchi H., Hamazaki K., Hamazaki T., Matsuoka Y. Glutamatergic system abnormalities in posttraumatic stress disorder. Psychopharmacology (Berl). 2015; 232(23): 4261–4268. doi: http://dx.doi.org/10.1007/10.1007/s00213-015-4052-5.
   Google Scholar
• O'Donnell T., Hegadoren K.M., Coupland N.C. Noradrenergic mechanisms in the pathophysiology of posttraumatic stress disorder. Neuropsychobiology. 2004; 50(4): 273–283. doi: http://dx.doi.org/10.1007/10.1159/000080952.
   Google Scholar
• Olff M., Koch S.B., Nawijn L., Frijling J.L., Van Zuiden M., Veltman D.J. Social support, oxytocin, and PTSD. European Journal of Psychotraumatology. 2014; 5: 26513. doi: http://dx.doi.org/10.1007/10.3402/ejpt.v5.26513.
   Google Scholar
• Pamplona F.A., Bitencourt R.M., Takahashi R.N. Short- and long-term effects of cannabinoids on the extinction of contextual fear memory in rats. Neurobiology of Learning and Memory. 2008; 90(1): 290–293. doi: http://dx.doi.org/10.1007/10.1016/j.nlm.2008.04.003.
   Google Scholar
• Pennington D.L., Abe C., Batki S.L., Meyerhoff D.J. A preliminary examination of cortical neurotransmitter levels associated with heavy drinking in posttraumatic stress disorder. Psychiatry Research. 2014; 224(3): 281–287. doi: http://dx.doi.org/10.1016/j.pscychresns.2014.09.004.
   Google Scholar
• Perry B.D. , Giller E.L. Jr , Southwick S.M . Altered platelet alpha 2-adrenergic binding sites in posttraumatic stress disorder. American Journal of Psychiatry. 1987; 144(11): 1511–1512.
   Google Scholar
• Petrakis I.L., Desai N., Gueorguieva R., Arias A., O'Brien E., Jane J.S., …Ralevski E. Prazosin for veterans with posttraumatic stress disorder and comorbid alcohol dependence: A clinical trial. Alcoholism: Clinical and Experimental Research. 2016; 40(1): 178–186. doi: http://dx.doi.org/10.1111/acer.12926.
   Google Scholar
• Petrakis I.L., Ralevski E., Desai N., Trevisan L., Gueorguieva R., Rounsaville B., …, Krystal J.H. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012; 37(4): 996–1004. doi: http://dx.doi.org/10.1038/npp.2011.283.
   Google Scholar
• Pietrzak R.H., Gallezot J.D., Ding Y.S., Henry S., Potenza M.N., Southwick S.M., …Neumeister A. Association of posttraumatic stress disorder with reduced in vivo norepinephrine transporter availability in the locus coeruleus. JAMA Psychiatry. 2013; 70(11): 1199–1205. doi: http://dx.doi.org/10.1001/jamapsychiatry.2013.399.
   Google Scholar
• Pietrzak R.H., Goldstein R.B., Southwick S.M., Grant B.F. Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: Results from wave 2 of the National Epidemiologic Survey on alcohol and related conditions. Journal of Anxiety Disorders. 2011; 25(3): 456–465. doi: http://dx.doi.org/10.1016/j.janxdis.2010.11.010.
   Google Scholar
• Pitman R.K., Rasmusson A.M., Koenen K.C., Shin L.M., Orr S.P., Gilbertson M.W., …Liberzon I. Biological studies of posttraumatic stress disorder. Natural Reviews Neuroscience. 2012; 13(11): 769–787. doi: http://dx.doi.org/10.1038/nrn3339.
   Google Scholar
• Pollack M.H., Jensen J.E., Simon N.M., Kaufman R.E., Renshaw P.F. High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: Response to treatment with levetiracetam. Progress in Neuropsychopharmacology and Biology Psychiatry. 2008; 32(3): 739–743. doi: http://dx.doi.org/10.1016/j.pnpbp.2007.11.023.
   Google Scholar
• Ramboz S. , Oosting R. , Amara D.A. , Kung H.F. , Blier P. , Mendelsohn M. , … Hen R . Serotonin receptor 1A knockout: An animal model of anxiety-related disorder. Proceedings of National Academy of Sciences USA. 1998; 95(24): 14476–14481.
   Google Scholar
• Raskind M.A., Peterson K., Williams T., Hoff D.J., Hart K., Holmes H., …Peskind E.R. A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. American Journal of Psychiatry. 2013; 170(9): 1003–1010. doi: http://dx.doi.org/10.1176/appi.ajp.2013.12081133.
   Google Scholar
• Rogan M.T., Staubli U.V., LeDoux J.E. Fear conditioning induces associative long-term potentiation in the amygdala. Nature. 1997; 390(6660): 604–607. doi: http://dx.doi.org/10.1038/37601.
   Google Scholar
• Roozendaal B., Barsegyan A., Lee S. Adrenal stress hormones, amygdala activation, and memory for emotionally arousing experiences. Progress in Brain Research. 2008; 167: 79–97. doi: http://dx.doi.org/10.1016/S0079-6123(07)67006-X.
   Google Scholar
• Rothbaum B.O., Price M., Jovanovic T., Norrholm S.D., Gerardi M., Dunlop B., Ressler K.J. A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans. American Journal of Psychiatry. 2014; 171(6): 640–648. doi: http://dx.doi.org/10.1176/appi.ajp.2014.13121625.
   Google Scholar
• Sabban E.L., Alaluf L.G., Serova L.I. Potential of neuropeptide Y for preventing or treating posttraumatic stress disorder. Neuropeptides. 2015; 56: 19–24.
   Google Scholar
• Sari Y. Serotonin1B receptors: From protein to physiological function and behavior. Neuroscience and Biobehavioral Reviews. 2004; 28(6): 565–582. doi: http://dx.doi.org/10.1016/j.neubiorev.2004.08.008.
   Google Scholar
• Saxe G., Stoddard F., Courtney D., Cunningham K., Chawla N., Sheridan R., …King L. Relationship between acute morphine and the course of PTSD in children with burns. Journal of American Academy of Child and Adolescent Psychiatry. 2001; 40(8): 915–921. doi: http://dx.doi.org/10.1097/00004583-200108000-00013.
   Google Scholar
• Schonenberg M., Reichwald U., Domes G., Badke A., Hautzinger M. Effects of peritraumatic ketamine medication on early and sustained posttraumatic stress symptoms in moderately injured accident victims. Psychopharmacology (Berl). 2005; 182(3): 420–425. doi: http://dx.doi.org/10.1007/s00213-005-0094-4.
   Google Scholar
• Schonenberg M., Reichwald U., Domes G., Badke A., Hautzinger M. Ketamine aggravates symptoms of acute stress disorder in a naturalistic sample of accident victims. Journal of Psychopharmacology. 2008; 22(5): 493–497. doi: http://dx.doi.org/10.1177/0269881107082481.
   Google Scholar
• Seal K.H., Metzler T.J., Gima K.S., Bertenthal D., Maguen S., Marmar C.R. Trends and risk factors for mental health diagnoses among Iraq and Afghanistan veterans using Department of Veterans Affairs health care, 2002–2008. American Journal of Public Health. 2009; 99(9): 1651–1658. doi: http://dx.doi.org/10.2105/AJPH.2008.150284.
   Google Scholar
• Silva A.P. , Xapelli S. , Grouzmann E. , Cavadas C . The putative neuroprotective role of neuropeptide Y in the central nervous system. Current Drug Targets and CNS Neurological Disorders. 2005; 4(4): 331–347.
   Google Scholar
• Southwick S.M. , Bremner J.D. , Rasmusson A. , Morgan C.A., 3rd , Arnsten A. , Charney D.S . Role of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder. Biological Psychiatry. 1999; 46(9): 1192–1204.
   Google Scholar
• Southwick S.M. , Krystal J.H. , Bremner J.D. , Morgan C.A., 3rd , Nicolaou A.L. , Nagy L.M., … , Charney D.S . Noradrenergic and serotonergic function in posttraumatic stress disorder. Archives of General Psychiatry. 1997; 54(8): 749–758.
   Google Scholar
• Southwick S.M. , Morgan C.A., 3rd , Bremner A.D. , Grillon C.G. , Krystal J.H. , Nagy L.M., … , Charney D.S . Noradrenergic alterations in posttraumatic stress disorder. Annals of the New York Academy of Sciences. 1997; 821: 125–141.
   Google Scholar
• Sullivan G.M., Ogden R.T., Huang Y.Y., Oquendo M.A., Mann J.J., Parsey R.V. Higher in vivo serotonin-1a binding in posttraumatic stress disorder: A PET study with [11C]WAY-100635. Depression and Anxiety. 2013; 30(3): 197–206. doi: http://dx.doi.org/10.1002/da.22019.
   Google Scholar
• Taylor F.B., Martin P., Thompson C., Williams J., Mellman T.A., Gross C., Raskind M.A. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: A placebo-controlled study. Biological Psychiatry. 2008; 63(6): 629–632. doi: http://dx.doi.org/10.1016/j.biopsych.2007.07.001.
   Google Scholar
• van Minnen A. , Arntz A. , Keijsers G.P . Prolonged exposure in patients with chronic PTSD: Predictors of treatment outcome and dropout. Behavioral Research and Therapeutics. 2002; 40(4): 439–457.
   Google Scholar
• Varvel S.A., Wise L.E., Niyuhire F., Cravatt B.F., Lichtman A.H. Inhibition of fatty-acid amide hydrolase accelerates acquisition and extinction rates in a spatial memory task. Neuropsychopharmacology. 2007; 32(5): 1032–1041. doi: http://dx.doi.org/10.1038/sj.npp.1301224.
   Google Scholar
• Viola J. , Ditzler T. , Batzer W. , Harazin J. , Adams D. , Lettich L., … , Berigan T . Pharmacological management of posttraumatic stress disorder: Clinical summary of a five-year retrospective study, 1990–1995. Military Medicine. 1997; 162(9): 616–619.
   Google Scholar
• Wilkinson S.T., Yarnell S., Radhakrishnan R., Ball S.A., D'Souza D.C. Marijuana legalization: Impact on physicians and public health. Annual Review of Medicine. 2016; 67: 453–466. doi: http://dx.doi.org/10.1146/annurev-med-050214-013454.
   Google Scholar
• Yarnell S. The use of medicinal marijuana for posttraumatic stress disorder: A review of the current literature. The Primary Care Companion for CNS Disorders. 2015; 17(3): doi: http://dx.doi.org/10.4088/PCC.15r01786.
   Google Scholar
• Yeh M.S., Mari J.J., Costa M.C., Andreoli S.B., Bressan R.A., Mello M.F. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD. CNS Neuroscience and Therapeutics. 2011; 17(5): 305–310. doi: http://dx.doi.org/10.1111/j.1755-5949.2010.00188.x.
   Google Scholar
• Young M.B., Andero R., Ressler K.J., Howell L.L. 3,4-Methylenedioxymethamphetamine facilitates fear extinction learning. Translational Psychiatry. 2015; 5: e634. doi: http://dx.doi.org/10.1038/tp.2015.138.
   Google Scholar
• Zohar J. , Amital D. , Miodownik C. , Kotler M. , Bleich A. , Lane R.M., … , Austin C . Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. Journal of Clinical Psychopharmacology. 2002; 22(2): 190–195.
   Google Scholar